Pharmacoeconomics: Open Access

Volume 10, Issue 5 (2025)

Perspective Pages: 1 - 3

Rare Disease Therapies: Bridging Economic and Access Gaps

Helen Murray*

DOI: 10.37421/2472-1042.2025.10.306

Share this article

Brief Report Pages: 1 - 2

Pharmacogenomics: A Cost- Effective Path to Better Care

Ricardo M. Fonseca*

DOI: 10.37421/2472-1042.2025.10.301

Share this article

Brief Report Pages: 1 - 3

Cost-Effectiveness of Mental Health Interventions: A Review

Yara El-Sayed*

DOI: 10.37421/2472-1042.2025.10.302

Share this article

Opinion Pages: 1 - 3

Biosimilars: Affordable Access, Enhanced Healthcare in Developing Nations

Nathaniel Brooks*

DOI: 10.37421/2472-1042.2025.10.303

Share this article

Opinion Pages: 1 - 3

Cancer Immunotherapy Costs: Real-world Economic Considerations

Ivana KostiÄ?*

DOI: 10.37421/2472-1042.2025.10.304

Share this article

Perspective Pages: 1 - 3

Funding Rare Disease Therapies: Equitable Access Strategies

Suraj Venkatesan*

DOI: 10.37421/2472-1042.2025.10.305

Share this article

Commentary Pages: 1 - 3

Preventive Pharmacotherapy: Superior Long-term Cost-Effectiveness

Faisal Al-Khalid**

DOI: 10.37421/2472-1042.2025.10.307

Share this article

Commentary Pages: 1 - 2

The Steep Economic Cost of Medication Non-adherence

Anika Verhoeven*

DOI: 10.37421/2472-1042.2025.10.308

Share this article

Short Communication Pages: 1 - 3

Cost-Benefit Analysis in Public Health Drug Policies

Marco De Santis*

DOI: 10.37421/2472-1042.2025.10.309

Share this article

Short Communication Pages: 1 - 3

Fixed-dose Combinations: Better Outcomes, Lower Costs

Chinedu Okorie*

DOI: 10.37421/2472-1042.2025.10.310

Share this article

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 106

Pharmacoeconomics: Open Access received 106 citations as per Google Scholar report

Volume 10, Issue 5 (2025)

Rare Disease Therapies: Bridging Economic and Access Gaps

Pharmacogenomics: A Cost- Effective Path to Better Care

Cost-Effectiveness of Mental Health Interventions: A Review

Biosimilars: Affordable Access, Enhanced Healthcare in Developing Nations

Cancer Immunotherapy Costs: Real-world Economic Considerations

Funding Rare Disease Therapies: Equitable Access Strategies

Preventive Pharmacotherapy: Superior Long-term Cost-Effectiveness

The Steep Economic Cost of Medication Non-adherence

Cost-Benefit Analysis in Public Health Drug Policies

Fixed-dose Combinations: Better Outcomes, Lower Costs

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 106

Pharmacoeconomics: Open Access peer review process verified at publons

Indexed In

Related Links

Open Access Journals